Michael Hennig Selected Research

Michael Hennig Research Topics

Disease

8	Atherosclerosis 09/2009 - 11/2002
5	Neoplasms (Cancer) 05/2012 - 04/2006
4	Type 2 Diabetes Mellitus (MODY) 02/2010 - 01/2005
3	Ascites 06/2014 - 01/2012
3	Carotid Artery Diseases 05/2005 - 11/2002
2	Alzheimer Disease (Alzheimer's Disease) 06/2013 - 02/2008
2	Carcinoma (Carcinomatosis) 01/2012 - 09/2007
2	Infections 04/2011 - 03/2003
2	Adenocarcinoma 09/2007 - 01/2005
2	Hypertension (High Blood Pressure) 02/2007 - 11/2002
2	Chronic Renal Insufficiency 05/2003 - 06/2002
1	Hyperplasia 01/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018
1	Disease Progression 01/2018
1	Eye Diseases (Eye Disease) 01/2018
1	Eczema 11/2016
1	Vascular Diseases (Vascular Disease) 05/2016
1	Melanoma (Melanoma, Malignant) 03/2014
1	Long QT Syndrome 02/2013
1	Hypersensitivity (Allergy) 07/2012
1	Autoimmune Diseases (Autoimmune Disease) 02/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2011
1	Abdominal Pain (Pain, Abdominal) 01/2011
1	Vomiting 01/2011
1	Peritoneal Neoplasms 01/2011
1	Fever (Fevers) 01/2011
1	Obesity 08/2009
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2007
1	Esophageal Neoplasms (Esophageal Cancer) 09/2007
1	Lymphatic Metastasis 09/2007
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2007
1	Inflammation (Inflammations) 02/2007
1	Diabetes Mellitus 04/2006
1	Colorectal Neoplasms (Colorectal Cancer) 04/2006
1	Heart Diseases (Heart Disease) 05/2005
1	Radiation Pneumonitis 01/2005
1	Lung Neoplasms (Lung Cancer) 01/2005

Drug/Important Bio-Agent (IBA)

8	lacidipineIBA 09/2009 - 11/2002
6	Antihypertensive Agents (Antihypertensives)IBA 09/2009 - 11/2002
6	Atenolol (Tenormin)FDA LinkGeneric 05/2007 - 11/2002
5	Pharmaceutical PreparationsIBA 01/2018 - 05/2005
4	catumaxomabIBA 06/2014 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2004
2	Biomarkers (Surrogate Marker)IBA 06/2014 - 03/2014
2	EnzymesIBA 06/2013 - 02/2010
2	Epithelial Cell Adhesion MoleculeIBA 01/2012 - 01/2011
2	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2010 - 01/2005
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 08/2009 - 04/2006
2	LipidsIBA 08/2009 - 02/2007
2	ParaffinIBA 09/2007 - 04/2006
2	Plasminogen Activator Inhibitor 1IBA 02/2007 - 05/2004
2	CalciumIBA 05/2005 - 11/2002
2	Theophylline (Theon)FDA LinkGeneric 05/2003 - 06/2002
2	CreatinineIBA 05/2003 - 06/2002
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Dutasteride (Avodart)FDA Link 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Rhodopsin (Visual Purple)IBA 01/2018
1	Alitretinoin FDA Link 11/2016
1	oxidized low density lipoproteinIBA 05/2016
1	Dacarbazine (DIC)FDA LinkGeneric 03/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2013
1	Serine Proteases (Serine Protease)IBA 07/2012
1	Chymases (Chymase)IBA 07/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	CytokinesIBA 01/2012
1	Benzene (Benzole)IBA 04/2011
1	HalogensIBA 04/2011
1	ThioamidesIBA 04/2011
1	voclosporinIBA 02/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2011
1	carmegliptinIBA 02/2010
1	TyramineIBA 02/2008
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2008
1	Vascular Endothelial Growth Factor CIBA 09/2007
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 07/2007
1	InterleukinsIBA 02/2007
1	C-Reactive ProteinIBA 02/2007
1	Peptides (Polypeptides)IBA 02/2007
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2007
1	Insulin (Novolin)FDA Link 02/2007
1	Glucose (Dextrose)FDA LinkGeneric 02/2007
1	RNA (Ribonucleic Acid)IBA 04/2006
1	PalmitoylcarnitineIBA 04/2006
1	Thymidylate SynthaseIBA 04/2006
1	Messenger RNA (mRNA)IBA 04/2006
1	ST1326IBA 04/2006
1	Thymidine PhosphorylaseIBA 04/2006
1	Formaldehyde (Formol)FDA Link 04/2006
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 04/2006
1	Cyclophilins (Cyclophilin)IBA 05/2005
1	Protein Isoforms (Isoforms)IBA 05/2005
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2005

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2012
2	Immunotherapy 05/2012 - 01/2011
2	Drug Therapy (Chemotherapy) 04/2006 - 01/2005
2	Radiotherapy 01/2005 - 01/2005
1	Aftercare (After-Treatment) 01/2012